Weight Loss Screening & Follow-Up Tests for GLP-1 Therapy: A Complete Safety Guide

Weight loss medications like Ozempic, Mounjaro, and Wegovy have changed the way medical weight management works. These GLP-1 drugs help control appetite, blood sugar, and metabolism, but they also affect multiple organs in the body. 

This is why testing before and during GLP-1 therapy is not optional, it’s essential. 

Pathkind’s Weight Loss Screening Package (Pre-GLP-1 Therapy) and Weight Loss Follow-Up Package (During GLP-1 Therapy) are designed to help you begin and continue your weight-loss journey safely, with clarity and medical confidence. 

Why Testing Matters in GLP-1 Based Weight Loss 

GLP-1 medications influence: 

• Blood sugar regulation 
• Liver and kidney function 
• Thyroid activity 
• Pancreatic enzymes 
• Electrolyte balance 

Many people focus only on weight reduction, but safe weight loss is about what’s happening inside your body. Testing helps catch silent issues before they become serious. 

Weight Loss Screening Package (Pre-GLP-1 Therapy) 

Thinking about starting GLP-1 therapy? Before the first injection, your body needs a baseline health assessment. 

The Weight Loss Screening Package evaluates how well your organs and metabolism are functioning, ensuring your body is prepared for GLP-1 medication. 

This package checks 57 critical parameters related to blood sugar, liver, kidney, thyroid, lipid, and pancreatic health. 

Why Choose the Pre-Therapy Screening Package? 

Baseline Safety Check 

• Understand your health status before starting medication. 

Comprehensive Coverage 

• 57 parameters linked to metabolic and organ health. 

Doctor-Recommended Approach 

• Helps reduce the risk of side effects once therapy begins. 

Personalized Insight 

• Identifies areas that may need correction before treatment. 

Trusted Diagnostic Accuracy 

• Conducted using Pathkind’s advanced analyzers and protocols. 

Key Benefits 

• Detect liver, kidney, or thyroid imbalances early 
• Reduce the risk of complications during GLP-1 therapy 
• Start weight-loss treatment with confidence 
• Share clear, actionable reports with your doctor 

Who Should Take This Package? 

• Individuals planning GLP-1 therapy (Ozempic, Mounjaro, Wegovy) 
• People exploring medical weight-loss options 
• Patients advised to check baseline metabolic health 
• Anyone who wants a safe, informed start to weight loss 

Test Highlights (57 Parameters) 

Includes: 

• Complete Blood Count (CBC) 
• Fasting Plasma Glucose 
• HbA1c 
• Lipid Profile 
• Liver Function Test 
• Kidney Profile with Urine Analysis 
• Thyroid (TSH-3rd Generation) 
• Amylase & Lipase 
• Calcitonin 

Pre-Test Guidelines

• Fast for 8-10 hours 
• Avoid unprescribed medicines on test day 
• Inform the technician about diabetes or thyroid medication 

Weight Loss Follow-Up Package (During GLP-1 Therapy)

Already taking GLP-1 injections and feeling fine? That’s great but many side effects develop silently before symptoms appear. 

The Weight Loss Follow-Up Package helps monitor how your body is responding to therapy over time. It focuses on 46 essential parameters to ensure continued safety and effectiveness. 

Why Choose the Follow-Up Package? 

Ongoing Health Monitoring 

• Tracks organ function during therapy. 

Early Detection of Side Effects 

• Identifies issues before they become serious. 

Clinically Relevant Testing 

• Aligned with medical guidelines for GLP-1 monitoring. 

Supports Long-Term Success 

Helps maintain safe, sustainable weight loss. 

Key Benefits 

• Monitors liver, kidney, thyroid, and glucose levels 
• Detects early signs of pancreatic or electrolyte imbalance 
• Helps evaluate therapy effectiveness 
• Provides reassurance throughout treatment 

Who Should Take This Package? 

• Individuals currently on GLP-1 therapy 
• Patients on prescription-based weight-loss plans 
• Those experiencing nausea, fatigue, or appetite changes 
• Anyone committed to safe, long-term weight management 

Test Highlights (46 Parameters) 

Includes: 

• HbA1c 
• Fasting Plasma Glucose 
• Liver Function Test 
• Kidney Profile with Urine Analysis 
• Amylase & Lipase 

Follow-Up Test Guidelines

• Fast for 8-10 hours 
• Inform the technician about GLP-1 dosage and duration 
• Avoid heavy exercise and high-fat meals 24 hours prior 

How Often Should You Get Tested? 

• Before starting GLP-1 therapy: Once (baseline) 
• During therapy: Every 3-4 months or as advised by your doctor 

Regular testing helps ensure weight loss stays healthy not harmful.

Final Takeaway 

GLP-1 medications can be powerful tools for weight loss-but only when used responsibly. 

The Weight Loss Screening Package helps you start safely. 

The Weight Loss Follow-Up Package helps you stay safe. 

Together, they support a weight-loss journey that is informed, monitored, and medically sound because real health is about more than just the number on the scale.